Carla B. Ripamonti - Concepedia

Author

Carla B. Ripamonti

Fondazione IRCCS Istituto Nazionale dei Tumori ORCID

Also Known As

C B Ripamonti, C Ripamonti, C. B. Ripamonti, C. Ripamonti, C.B. Ripamonti, CARLA B. RIPAMONTI, Carla B Ripamonti, Carla B. Ripamonti, Carla Barbara Ripamonti, Carla Ripamonti

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan IFOM European Institute of Oncology Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

About

Carla B. Ripamonti is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, genetics, and systems biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	464
2	Health Sciences	2	2	22
3	Engineering	1	1	62
4	Public Health	1	1	26
5	Allergy	1	1	40

Carla B. Ripamonti

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
C-kit mutations in core binding factor leukemias Alessandro Beghini, Paolo Peterlongo, Carla B. Ripamonti, Blood	2000	299
Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer Christopher A. Maxwell, Javier Benítez, Laia Gómez‐Baldó, PLoS Biology	2011	192
RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia Alessandro Beghini, Carla B. Ripamonti, Paolo Peterlongo, Human Molecular Genetics Mixed-phenotype Acute LeukemiaGeneticsRna SplicingImmunologyPtpn6 Mrna	2000	166
KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication. Alessandro Beghini, Carla B. Ripamonti, Roberto Cairoli, PubMed	2004	162
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin Paolo Bossi, Diego Cortinovis, Sonia Fatigoni, Annals of Oncology	2017	85
Amplification of a novel c-Kit activating mutation Asn822-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia Alessandro Beghini, Ivana Magnani, Carla B. Ripamonti, The Hematology Journal Hematological MalignancyMixed-phenotype Acute LeukemiaAcute Myeloid LeukemiaMutation Asn822-lysHematology	2002	69
Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations Mara Colombo, Giovanna De Vecchi, Laura Caleca, PLoS ONE EngineeringGeneticsPathologySplice Site VariantsGene Characterization	2013	62
Analysis of a set of missense, frameshift, and in-frame deletion variants of BRCA1 Marcelo A. Carvalho, Maria A. Pino, Rachel Karchin, Mutation research. Fundamental and molecular mechanisms of mutagenesis GeneticsIn-frame Deletion VariantsSystems Biology	2008	43
First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report Carla B. Ripamonti, Mara Colombo, P Mondini, BMC Cancer	2013	40
Trisomy 4 Leading to Duplication of a Mutated KIT Allele in Acute Myeloid Leukemia with Mast Cell Involvement Alessandro Beghini, Carla B. Ripamonti, Pierangela Castorina, Cancer Genetics and Cytogenetics Hematological MalignancyChromatinAllergyMast Cell InvolvementCytogenetics	2000	40

Page 1